• Je něco špatně v tomto záznamu ?

Side Effects of COVID-19 Vaccines Primer Doses: Experience of Saudi Healthcare Workers Participating in CoVaST-SA

A. Riad, SS. Alsaad, AA. Almurikhi, FA. Alzahrani, AM. Alghamdi, EH. Alzaid, M. Klugar

. 2022 ; 10 (12) : . [pub] 20221213

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc22031046

BACKGROUND: Side effects emerging after COVID-19 vaccines may adversely impact public confidence in vaccines. Therefore, this study was designed to explore the short-term side effects of COVID-19 vaccines as a part of the COVID-19 Vaccines Safety Tracking (CoVaST) study. METHODS: A cross-sectional survey-based study was carried out to collect data from healthcare workers (HCWs) in Saudi Arabia. The study was initiated between June and December 2021. A validated questionnaire was used in this study consisting of four categories, including demographic characteristics and medical anamnesis of the participants, COVID-19-associated anamnesis, and side effects of vaccine uptake. RESULTS: The study included 1039 participants, of which 70.2% were females, and their median age was 34. About 82.9% and 52.3% of the participants reported a minimum of both one local and systemic side effect, respectively. Females, young participants (≤34 years old), and non-obese participants had more potential to disclose post-vaccination side effects than their counterparts. Heterologous schedules and viral vector-based vaccines were linked with a greater rate of systemic side effects, whereas homologous vaccination schedules and mRNA-based vaccines were linked with a greater rate of local side effects. CONCLUSION: Future studies on COVID-19 vaccines should focus on the role of BMI, previous infection, and vaccination schedule in terms of vaccine safety and reactogenicity.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc22031046
003      
CZ-PrNML
005      
20230127131026.0
007      
ta
008      
230119s2022 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/vaccines10122137 $2 doi
035    __
$a (PubMed)36560547
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Riad, Abanoub $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic $u Institute of Health Information and Statistics of the Czech Republic, 128 01 Prague, Czech Republic $1 https://orcid.org/0000000159188966
245    10
$a Side Effects of COVID-19 Vaccines Primer Doses: Experience of Saudi Healthcare Workers Participating in CoVaST-SA / $c A. Riad, SS. Alsaad, AA. Almurikhi, FA. Alzahrani, AM. Alghamdi, EH. Alzaid, M. Klugar
520    9_
$a BACKGROUND: Side effects emerging after COVID-19 vaccines may adversely impact public confidence in vaccines. Therefore, this study was designed to explore the short-term side effects of COVID-19 vaccines as a part of the COVID-19 Vaccines Safety Tracking (CoVaST) study. METHODS: A cross-sectional survey-based study was carried out to collect data from healthcare workers (HCWs) in Saudi Arabia. The study was initiated between June and December 2021. A validated questionnaire was used in this study consisting of four categories, including demographic characteristics and medical anamnesis of the participants, COVID-19-associated anamnesis, and side effects of vaccine uptake. RESULTS: The study included 1039 participants, of which 70.2% were females, and their median age was 34. About 82.9% and 52.3% of the participants reported a minimum of both one local and systemic side effect, respectively. Females, young participants (≤34 years old), and non-obese participants had more potential to disclose post-vaccination side effects than their counterparts. Heterologous schedules and viral vector-based vaccines were linked with a greater rate of systemic side effects, whereas homologous vaccination schedules and mRNA-based vaccines were linked with a greater rate of local side effects. CONCLUSION: Future studies on COVID-19 vaccines should focus on the role of BMI, previous infection, and vaccination schedule in terms of vaccine safety and reactogenicity.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Alsaad, Safa S $u Department of Family Medicine, King Fahad Specialist Hospital, Dammam 32253, Saudi Arabia $1 https://orcid.org/0000000163451114
700    1_
$a Almurikhi, Ali A $u Department of Family Medicine, King Fahad Specialist Hospital, Dammam 32253, Saudi Arabia
700    1_
$a Alzahrani, Fayez A $u Department of Family Medicine, King Fahad Specialist Hospital, Dammam 32253, Saudi Arabia
700    1_
$a Alghamdi, Ali M $u Department of Infectious Diseases, King Fahad Specialist Hospital, Dammam 32253, Saudi Arabia
700    1_
$a Alzaid, Esra H $u Department of Family Medicine, King Fahad Specialist Hospital, Dammam 32253, Saudi Arabia
700    1_
$a Klugar, Miloslav $u Czech National Centre for Evidence-Based Healthcare and Knowledge Translation (Cochrane Czech Republic, Czech EBHC: JBI Centre of Excellence, Masaryk University GRADE Centre), Faculty of Medicine, Masaryk University, 625 00 Brno, Czech Republic $u Institute of Health Information and Statistics of the Czech Republic, 128 01 Prague, Czech Republic $1 https://orcid.org/0000000228047295
773    0_
$w MED00200686 $t Vaccines $x 2076-393X $g Roč. 10, č. 12 (2022)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/36560547 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y p $z 0
990    __
$a 20230119 $b ABA008
991    __
$a 20230127131018 $b ABA008
999    __
$a ok $b bmc $g 1889352 $s 1182379
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2022 $b 10 $c 12 $e 20221213 $i 2076-393X $m Vaccines $n Vaccines (Basel) $x MED00200686
LZP    __
$a Pubmed-20230119
Zpět

Najít záznam

Citační ukazatele

Možnosti archivace